Lab
Ammvr Group, INC
Ammvr Group, INC was paid $6.72M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 87536, — 27% of everything it billed.
33Billing provider infoAMMVR GROUP, INC
HATO REY, PR 00919
HATO REY, PR 00919
33aNPI1447477252assigned 04/20/2007
33bProvider typeClinical Medical Laboratory
28Total paid$6.72M
24GClaims366,511
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#11 of 777
Median peer was paid$278K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,433 | $778K | |
| 2019 | 41,499 | $680K | |
| 2020 | 54,419 | $1.00M | |
| 2021 | 62,253 | $1.18M | |
| 2022 | 50,440 | $942K | |
| 2023 | 59,599 | $1.01M | |
| 2024incomplete | 57,868 | $1.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87536 | 27% | 21,954 | 20,453 | $1.84M | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.3% | 11,741 | 10,632 | $421K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.2% | 11,789 | 10,675 | $415K |
| 80061 | Lipid panel | 5.6% | 29,719 | 27,538 | $377K |
| 86361 | 5.3% | 13,552 | 12,431 | $360K | |
| 86360 | 5.1% | 7,624 | 7,350 | $342K | |
| 80053 | Comprehensive metabolic panel | 4.2% | 30,256 | 27,863 | $283K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 5,815 | 5,348 | $279K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.5% | 34,501 | 31,303 | $237K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.3% | 9,649 | 8,670 | $223K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.3% | 16,059 | 14,613 | $219K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.0% | 5,509 | 4,899 | $201K |
78 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.6% | 6,950 | $174K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.3% | 16,484 | $153K |
| 81000 | 1.4% | 30,752 | $92K | |
| 84153 | 1.1% | 4,350 | $76K | |
| 86803 | <1% | 4,428 | $60K | |
| 86738 | <1% | 4,773 | $58K | |
| 83690 | <1% | 6,871 | $48K | |
| 82150 | <1% | 7,184 | $47K | |
| 86704 | <1% | 4,000 | $46K | |
| 86708 | <1% | 3,978 | $46K | |
| 86328 | <1% | 2,243 | $44K | |
| 82043 | <1% | 8,263 | $44K | |
| 87276 | <1% | 3,761 | $43K | |
| 86706 | <1% | 4,192 | $42K | |
| 82274 | <1% | 2,847 | $40K | |
| 86593 | <1% | 9,279 | $40K | |
| 87340 | <1% | 4,007 | $38K | |
| 87275 | <1% | 3,774 | $38K | |
| 80074 | <1% | 834 | $36K | |
| 86777 | <1% | 2,280 | $33K | |
| 84439 | <1% | 3,394 | $30K | |
| 87522 | Neg quan hep c or qual rna | <1% | 610 | $27K |
| 86644 | <1% | 1,860 | $27K | |
| 82607 | <1% | 1,841 | $26K | |
| 80050 | General health panel | <1% | 2,267 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,456 | $19K |
| 86592 | <1% | 4,465 | $17K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,231 | $17K |
| 87088 | <1% | 2,188 | $16K | |
| 86645 | <1% | 674 | $12K | |
| 84436 | <1% | 1,698 | $10K | |
| 86696 | <1% | 524 | $10K | |
| 86778 | <1% | 680 | $10K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 153 | $8K |
| 86695 | <1% | 502 | $7K | |
| 87899 | <1% | 502 | $6K | |
| 84479 | <1% | 1,085 | $6K | |
| 86701 | <1% | 641 | $5K | |
| 82570 | <1% | 1,030 | $5K | |
| 84100 | <1% | 853 | $4K | |
| 85730 | <1% | 698 | $4K | |
| 86480 | <1% | 96 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 127 | $3K |
| 84460 | <1% | 703 | $3K | |
| 84450 | <1% | 706 | $3K | |
| 85610 | <1% | 769 | $3K | |
| 86709 | <1% | 288 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 393 | $2K |
| 80202 | <1% | 158 | $2K | |
| 84156 | <1% | 561 | $2K | |
| 82746 | <1% | 111 | $2K | |
| 86870 | <1% | 37 | $2K | |
| 82728 | <1% | 102 | $1K | |
| 82565 | <1% | 290 | $1K | |
| 86762 | <1% | 84 | $1K | |
| 86703 | <1% | 94 | $1K | |
| 84403 | <1% | 44 | $1K | |
| 84520 | <1% | 241 | $812.15 | |
| 86705 | <1% | 87 | $699.76 | |
| 82378 | <1% | 35 | $677.82 | |
| 83550 | <1% | 71 | $621.92 | |
| 85651 | <1% | 177 | $565.30 | |
| 84481 | <1% | 33 | $486.65 | |
| 86038 | <1% | 35 | $400.38 | |
| 85027 | <1% | 71 | $388.75 | |
| 84480 | <1% | 23 | $355.35 | |
| 86140 | <1% | 63 | $280.60 | |
| 82947 | <1% | 70 | $267.18 | |
| 82105 | <1% | 15 | $249.74 | |
| 83540 | <1% | 40 | $247.86 | |
| 86317 | <1% | 16 | $226.71 | |
| 87177 | <1% | 27 | $177.89 | |
| 80164 | <1% | 31 | $147.06 | |
| 82042 | <1% | 28 | $135.04 | |
| 82550 | <1% | 21 | $117.71 | |
| 80069 | <1% | 17 | $104.88 | |
| 82540 | <1% | 20 | $81.24 | |
| 82270 | <1% | 57 | $76.15 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTINEZ, JESUS (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Martinez Neurophysiology | Bartlett, TN | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.